1 Min Read
March 21 (Reuters) - Glenmark Pharmaceuticals Ltd:
* Says receives ANDA approval for clobetasol propionate ointment USP, 0.05% Source text: (bit.ly/2n2kRUp) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.